Does myasthenia gravis provide protection against cancer?

Acta Neurologica Scandinavica

Volumn 113, Issue SUPPL. 183, 2006, Pages 33-36

  Owe, J F ^a,b   Daltveit, A K ^a,c   Gilhus, N E ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Cancer; Cause of death; Death registration; Myasthenia gravis; Respiratory tract disease; Thymoma

Indexed keywords

ADULT; AGED; BREAST CANCER; CANCER; COLORECTAL CANCER; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CANCER; FEMALE; HUMAN; HYPOTHESIS; IMMUNOLOGICAL PARAMETERS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYASTHENIA GRAVIS; REGISTER; STOMACH CANCER; THYMOMA; AGE; ARTICLE; CASE CONTROL STUDY; CAUSE OF DEATH; IMMUNOLOGY; MIDDLE AGED; NEOPLASM; NORWAY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CAUSE OF DEATH; FEMALE; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; NEOPLASMS; NORWAY; REGISTRIES;

EID: 33645522810     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00612.x     Document Type: Conference Paper

References (15)

1. G arlepp MJ D awkins RL C hristiansen FT L awton J L uciani G M c L eod J et al. Autoimmunity in ocular and generalised myasthenia gravis. J Neuroimmunol 1981 1 325 32.
2. M arino M R icciardi R P inchera A B arbesino G M anetti L C hiovato L et al. Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J Clin Endocrinol Metab 1997 82 438 43.
3. T sao CY M endell JR L o WD L uquette M R ennebohm R. Myasthenia gravis and associated autoimmune diseases in children. J Child Neurol 2000 15 767 9.
4. L evin N A bramsky O L ossos A K arussis D S iegal T A rgov Z et al. Extrathymic malignancies in patients with myasthenia gravis. J Neurol Sci 2005 237 39 43.
5. M onden Y U yama T K imura S T aniki T. Extrathymic malignancy in patients with myasthenia gravis. Eur J Cancer 1991 27 745 7.
6. C arsons S. The association of malignancy with rheumatic and connective tissue diseases. Semin Oncol 1997 24 360 72.
7. E hrenfeld M A bu -S hakra M B uskila D S hoenfeld Y. The dual association between lymphoma and autoimmunity. Blood Cells Mol Dis 2001 27 750 6.
8. C onfavreux C S addier P G rimaud J M oreau T A deleine P A imard G. Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study. Neurology 1996 46 1607 12.
9. E voli A B atocchi AP T onali P M arciano M. Risk of cancer in patients with myasthenia gravis. Ann N Y Acad Sci 1998 841 742 5.
10. F raser AG O rchard TR R obinson EM J ewell DP. Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine. Aliment Pharmacol Ther 2002 16 1225 32.
11. P an CC C hen PC W ang LS C hi KH C hiang H. Thymoma is associated with an increased risk of second malignancy. Cancer 2001 92 2406 11.
12. W elsh JS W ilkins KB G reen R B ulkley G A skin F D iener -W est M et al. Association between thymoma and second neoplasms. JAMA 2000 283 1142 3.
13. P apatestas AE O sserman KE K ark AE. The relationship between thymus and oncogenesis. A study of the incidence of non thymic malignancy in myasthenia gravis. Br J Cancer 1971 25 635 45.
14. R amirez -M ontagut T T urk MJ W olchok JD G uevara -P atino JA H oughton AN. Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity. Oncogene 2003 22 3180 7.
15. O we JF D altveit AK G ilhus NE. Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001. J Neurol Neurosurg Psychiatry 2006 77 203 7.